NBIO
Price:
$0.0043
Market Cap:
$740.53K
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
Industry
Biotechnology
IPO Date
2009-12-03
Stock Exchange
OTC
Ticker
NBIO
According to Nascent Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.19. This represents a change of -65.52% compared to the average of 0.56 of the last 4 quarters.
The mean historical Current Ratio of Nascent Biotech, Inc. over the last ten years is 0.34. The current 0.19 Current Ratio has changed 5.56% with respect to the historical average. Over the past ten years (40 quarters), NBIO's Current Ratio was at its highest in in the September 2017 quarter at 4.19. The Current Ratio was at its lowest in in the June 2020 quarter at 0.00.
Average
0.34
Median
0.20
Minimum
0.00
Maximum
0.78
Discovering the peaks and valleys of Nascent Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.83%
Maximum Annual Current Ratio = 0.78
Minimum Annual Increase = -99.48%
Minimum Annual Current Ratio = 0.00
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.68 | 315.25% |
| 2023 | 0.16 | 21.16% |
| 2022 | 0.14 | -77.90% |
| 2021 | 0.61 | 54.83% |
| 2020 | 0.00 | -99.48% |
| 2019 | 0.21 | -62.76% |
| 2018 | 0.58 | -26.43% |
| 2017 | 0.78 | 305.08% |
| 2016 | 0.19 | 443.11% |
| 2015 | 0.04 | -51.63% |
The current Current Ratio of Nascent Biotech, Inc. (NBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.33
5-year avg
0.32
10-year avg
0.34
Nascent Biotech, Inc.’s Current Ratio is less than RegeneRx Biopharmaceuticals, Inc. (0.55), greater than ChitogenX Inc. (0.01), greater than Actavia Life Sciences, Inc. (0.05), less than BioSyntech, Inc. (0.45), greater than Wesana Health Holdings Inc. (0.11), less than Plant-Based Investment Corp. (16.96), greater than First Choice Healthcare Solutions, Inc. (0.00), less than Avivagen Inc. (0.61), greater than Real Brands, Inc. (0.03), greater than Pazoo, Inc. (0.01),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.55 | $290.00 | |
| 0.01 | $301.50K | |
| 0.05 | $3.09M | |
| 0.45 | $229.03K | |
| 0.11 | $244.77K | |
| 16.96 | $275.00 | |
| 0.00 | $197.75K | |
| 0.61 | $7.77K | |
| 0.03 | $26.91K | |
| 0.01 | $26.88K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nascent Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nascent Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Nascent Biotech, Inc.'s Current Ratio?
How is the Current Ratio calculated for Nascent Biotech, Inc. (NBIO)?
What is the highest Current Ratio for Nascent Biotech, Inc. (NBIO)?
What is the 3-year average Current Ratio for Nascent Biotech, Inc. (NBIO)?
What is the 5-year average Current Ratio for Nascent Biotech, Inc. (NBIO)?
How does the current Current Ratio for Nascent Biotech, Inc. (NBIO) compare to its historical average?